Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.365 SEK | +3.05% |
|
-4.64% | -8.33% |
Jun. 28 | Biovica to Provide Biomarker Testing for US Biopharmaceutical Company | MT |
Jun. 28 | Biovica International Signs New Agreement Supporting Pharma Development | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.33% | 18.88M | |
-37.33% | 8.55B | |
+14.86% | 3.8B | |
+7.38% | 2.44B | |
-25.96% | 1.87B | |
-17.30% | 1.74B | |
+36.49% | 1.19B | |
+32.58% | 830M | |
-7.64% | 711M | |
-18.37% | 589M |
- Stock Market
- Equities
- BIOVIC B Stock
- News Biovica International AB
- Transcript : Biovica International AB, Q3 2023 Earnings Call, Mar 17, 2023